Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Q3 2023 vs. Q2 2023
How the institutions holding Wave Life Sciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 81 | 85 | +4 |
| Shares | 72.2M | 72.6M | +432.2K (+0.6%) |
| Value | $262.7M | $417.4M | +$154.7M (+58.9%) |
New holders (11)
Institutions that held Wave Life Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 1,228,683 | $7.06M | 0.08% |
| TD Asset Management Inc | 162,692 | $935.5K | 0.00% |
| Walleye Capital LLC | 148,960 | $856.5K | 0.01% |
| Martingale Asset Management L P | 43,617 | $250.8K | 0.01% |
| Balyasny Asset Management LLC | 36,352 | $209.0K | 0.00% |
| SG Americas Securities, LLC | 25,868 | $149.0K | 0.00% |
| Jump Financial, LLC | 23,545 | $135.4K | 0.01% |
| Verition Fund Management LLC | 19,657 | $113.0K | 0.00% |
| Occudo Quantitative Strategies LP | 16,811 | $96.7K | 0.01% |
| AQR Capital Management LLC | 11,073 | $63.7K | 0.00% |
| Federated Hermes, Inc. | 314 | $1.81K | 0.00% |
Sold out (7)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 83,210 | $303.0K |
| Tudor Investment Corp Et Al | 42,217 | $153.7K |
| MetLife Investment Management | 31,423 | $114.4K |
| Franklin Resources Inc | 30,421 | $110.7K |
| Ergoteles LLC | 20,900 | $76.1K |
| Citadel Advisors LLC | 3,110 | $11.3K |
| Impact Partnership Wealth, LLC | 276 | $1.00K |